Needham & Company Reiterate Buy Following ResMed (RMD) Investor Meeting
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- Wall St climbs after August inflation report, oil price slide
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but on track for 8% weekly gain on supply concerns; US diesel hits record high
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Piper Jaffray Remains Bullish Following ResMed (RMD) Analyst Day; Says Recent Pullback was Overdone
June 8, 2015 9:10 AM EDTPiper Jaffray Maintains an Overweight and $80 price target on ResMed (NYSE: RMD) following an analyst day. There were no major data points from the meeting, however, analyst Matt O'Brien believes that the recent 26% pullback in the stock was overdone, and provides an attractive entry... More
